CN Patent

CN118812653A — 一种长效坎普他汀化合物

Assigned to Chengdu Aoda Biotechnology Co Ltd · Expires 2024-10-22 · 2y expired

What this patent protects

本发明涉及医药合成领域，公开了一种长效坎普他汀化合物。本发明所述一种长效化合物用于制备治疗疾病的药物组合物，所述药物组合物在预防和治疗干眼症、阵发性睡眠性血红蛋白尿症(PNH)、冷凝集素病(CAD)和C3肾小球肾炎等疾病中的应用。

USPTO Abstract

本发明涉及医药合成领域，公开了一种长效坎普他汀化合物。本发明所述一种长效化合物用于制备治疗疾病的药物组合物，所述药物组合物在预防和治疗干眼症、阵发性睡眠性血红蛋白尿症(PNH)、冷凝集素病(CAD)和C3肾小球肾炎等疾病中的应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN118812653A
Jurisdiction: CN
Classification: —
Expires: 2024-10-22
Drug substance claim: No
Drug product claim: No
Assignee: Chengdu Aoda Biotechnology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.